ADVFN ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Context Therapeutics Inc

Context Therapeutics Inc (CNTX)

0.632
-0.011
(-1.71%)
0.65
0.018
(2.85%)

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -5.29M-6.18M-6.93M-3.82M-3.09M-18.7M-4.31M-5.53M
Pre Tax Income -5.01M-5.87M-6.77M-3.67M-2.25M-17.46M-3.34M-4.58M
Net Income -5.01M-5.87M-6.77M-3.67M-2.25M-17.46M-3.34M-4.58M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -5.3M-6.17M-6.99M-3.82M-3.09M-18.7M-4.31M-5.54M
EBITDA -5.29M-6.18M-6.93M-3.82M-3.09M-18.7M-4.31M-5.53M
Year End December 30 2024 2021202220232024
USD ($)USD ($)USD ($)USD ($)
Total Revenue 0000
Operating Income -10.53M-15.88M-25.07M-29.92M
Pre Tax Income -10.46M-15.33M-23.96M-26.73M
Net Income -10.46M-15.34M-23.96M-26.73M
Preferred Dividends 0000
Basic Earnings Per Share (EPS) -0.327-0.961-1.501-0.356
EBIT -10.4M-15.88M-25.13M-29.93M
EBITDA -10.53M-15.87M-25.06M-29.91M

Your Recent History

Delayed Upgrade Clock